Conflictingly, CD44 positivity was found to decrease linearly with increasing cancer cell differentiation, leading to an increased Tumor Budding Activity (TBA) and a smaller Cell Nest Size (CNS), two key features driving the EMT process. The gene discussed is CD44; the disease is neoplasm.